UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040275
Receipt number R000045945
Scientific Title The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study
Date of disclosure of the study information 2020/04/30
Last modified on 2023/01/03 06:37:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study

Acronym

The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study

Scientific Title

The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study

Scientific Title:Acronym

The efficacy and safety of FOLFOXIRI for unresectable advanced rectal cancer : a prospective observational study

Region

Japan


Condition

Condition

Rectal Cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of FOLFOXIRI for patients with unresectable advanced rectal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Conversion Rate (R0 and R1 resection rate )

Key secondary outcomes

R0 resection rate
Response rate
Pathological response rate
Surgical morbidity and complications
The rate of early toxicity of neoadjuvant treatment
Relapse-free survival
Local relapse-free survival
Negative Circumferential Resection Margin


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Histologically confirmed colorectal adenocarcinoma
2.FOLFOXIRI as first-line
3.The lower margin of the tumor located between Rb and P
4.Clinical T4b or CRM positive by CT or MRI
5.M0 or M1 expected to be convertible with treatment
6.Age:20-80 years old
7.ECOG performance status 0-1
8.No prior chemotherapy or treatment such as rectal resection, pelvic lymph node dissection, or pelvic irradiation for any malignancies
9.Main organ function is maintained
10.Signed informed consent

Key exclusion criteria

1.Synchronous multiple malignancy or metachronous multiple malignancy within 5 years disease free interval.
2.Active infections, including HBs antigen positive
3.Body temperature >= 38 degrees Celsius
4.Serious complications
5.Currently treated with systemic steroids or immunosuppressive agents
6.Not appropriate for the trial by other reasons

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Shiozawa

Organization

Kanagawa Cancer Center

Division name

Department of Gastrointestinal Surgery

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

0455202222

Email

shiozawam@kcch.jp


Public contact

Name of contact person

1st name Nobuhiro
Middle name
Last name Sugano

Organization

Kanagawa Cancer Center

Division name

Department of Gastrointestinal Surgery

Zip code

241-8515

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa Prefecture

TEL

0455202222

Homepage URL


Email

nsugano@kcch.jp


Sponsor or person

Institute

Kanagawa Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Kanagawa Cancer Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kanagawa Cancer Center

Address

2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa prefecture

Tel

0455202222

Email

chiken-jimu4@kcch.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属病院(神奈川)、横浜南共済病院(神奈川)、藤沢湘南台病院(神奈川)、済生会横浜市南部病院(神奈川)、平塚共済病院(神奈川)、神奈川県立足柄上病院(神奈川)


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 04 Month 09 Day

Date of IRB

2020 Year 04 Month 20 Day

Anticipated trial start date

2020 Year 04 Month 30 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To clarify the safety and efficacy of prior surgery with FOLFOXIRI followed by surgery for advanced lower rectal cancer for which it is difficult to secure CRM in TME.


Management information

Registered date

2020 Year 04 Month 30 Day

Last modified on

2023 Year 01 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045945


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name